Published in Int J Clin Exp Med on August 22, 2012
A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Exp Ther Med (2013) 1.15
Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype. J Clin Endocrinol Metab (2013) 0.90
Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients. Int J Endocrinol (2013) 0.84
B-Raf mutation and papillary thyroid carcinoma patients. Oncol Lett (2016) 0.76
Appearance of malignant melanoma after a non-cutaneous cancer diagnosis. Ecancermedicalscience (2013) 0.75
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell (2004) 19.51
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 8.39
Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol (2008) 5.31
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39
Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol (2008) 3.30
Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett (2009) 3.19
Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid (2004) 2.83
BRAF(E600) in benign and malignant human tumours. Oncogene (2007) 2.45
The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg (2007) 2.36
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene (2005) 1.99
Molecular diagnostics and predictors in thyroid cancer. Thyroid (2009) 1.98
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab (2007) 1.95
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab (2007) 1.93
Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A (2007) 1.84
BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer (2008) 1.83
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells. J Clin Endocrinol Metab (2009) 1.59
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer (2006) 1.56
BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression. Cancer Res (2011) 1.47
BRAF is a therapeutic target in aggressive thyroid carcinoma. Clin Cancer Res (2006) 1.43
The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors. Mol Cell Endocrinol (2009) 1.40
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery (2010) 1.36
The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) (2005) 1.35
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation. Endocrinology (2006) 1.25
BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg (2012) 1.23
BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications. J Chin Med Assoc (2010) 1.18
PLX-4032, a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma. Curr Opin Investig Drugs (2010) 1.14
No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Clin Endocrinol (Oxf) (2005) 1.13
BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells. J Clin Endocrinol Metab (2007) 1.12
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer. Ann Surg Oncol (2011) 1.04
The utility of BRAF testing in the management of papillary thyroid cancer. Oncologist (2010) 1.03
BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy. Endocr Relat Cancer (2011) 0.90
BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients. APMIS (2011) 0.90
The molecular diagnosis and management of thyroid neoplasms. Curr Opin Oncol (2012) 0.82
Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann Surg Oncol (2014) 2.41
Triage and outcome of patients with mediastinal penetrating trauma. Ann Thorac Surg (2007) 2.06
Sophorolipids block lethal effects of septic shock in rats in a cecal ligation and puncture model of experimental sepsis. Crit Care Med (2006) 1.77
Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J (2011) 1.59
Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl (2003) 1.37
Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models. Cancer Res (2012) 1.26
Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol (2003) 1.22
American Thyroid Association statement on outpatient thyroidectomy. Thyroid (2013) 1.22
Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes. Stem Cells (2014) 1.20
Molecular characterization of exosome-like vesicles from breast cancer cells. BMC Cancer (2014) 1.11
The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers. Thyroid (2012) 1.06
Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction. Proc Natl Acad Sci U S A (2012) 1.04
Tumor-derived exosomes in oncogenic reprogramming and cancer progression. Cell Mol Life Sci (2014) 1.02
What is the best definitive treatment for Graves' disease? A systematic review of the existing literature. Ann Surg Oncol (2012) 1.01
Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species. Exp Biol Med (Maywood) (2010) 1.00
Appropriate and accurate diagnosis of thyroid nodules: a review of thyroid fine-needle aspiration. Int J Clin Exp Med (2013) 1.00
Phosphorylation of p50 NF-kappaB at a single serine residue by DNA-dependent protein kinase is critical for VCAM-1 expression upon TNF treatment. J Biol Chem (2010) 0.99
Protective effects of garlic and silymarin on NDEA-induced rats hepatotoxicity. Int J Biol Sci (2009) 0.98
Primary hyperparathyroidism. Otolaryngol Clin North Am (2010) 0.97
MicroRNA expression profiles in differentiated thyroid cancer, a review. Int J Clin Exp Med (2012) 0.95
PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth. Mol Med (2013) 0.95
Gender, race, and electrophysiologic characteristics of the branched recurrent laryngeal nerve. Laryngoscope (2014) 0.95
Gene transfer of extracellular SOD to the penis reduces O2-* and improves erectile function in aged rats. Am J Physiol Heart Circ Physiol (2002) 0.93
Myxofibrosarcoma with metastasis to the lungs, pleura, and mediastinum: a case report and review of literature. Int J Clin Exp Med (2012) 0.92
Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells. Int J Oncol (2003) 0.92
Prospective dual role of mesenchymal stem cells in breast tumor microenvironment. Breast Cancer Res Treat (2012) 0.91
A comparative North American experience of robotic thyroidectomy in a thyroid cancer population. Langenbecks Arch Surg (2013) 0.89
Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways. J Surg Res (2013) 0.89
Transoral robotic-assisted thyroidectomy with central neck dissection: preclinical cadaver feasibility study and proposed surgical technique. J Robot Surg (2011) 0.89
High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer. Carcinogenesis (2013) 0.88
Preoperative parathyroid needle localization: a minimally invasive novel technique in reoperative settings. Minim Invasive Surg (2011) 0.88
The role of the robotic-assisted transaxillary gasless approach for the removal of parathyroid adenomas. ORL J Otorhinolaryngol Relat Spec (2014) 0.88
Nicotinamide phosphoribosyltransferase and SIRT3 expression are increased in well-differentiated thyroid carcinomas. Anticancer Res (2013) 0.87
Clinical significance of CD146 and latexin during different stages of thyroid cancer. Mol Cell Biochem (2013) 0.87
Acute necrotizing pancreatitis following splenic artery embolization. Trop Gastroenterol (2012) 0.87
Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer. Int J Oncol (2010) 0.87
Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement. Head Neck (2014) 0.87
Considerations for personalized surgery in patients with papillary thyroid cancer. Thyroid (2010) 0.86
PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells. Prostate (2009) 0.86
The impact of surgical volume on racial disparity in thyroid and parathyroid surgery. Ann Surg Oncol (2014) 0.86
Thyroidectomy for Graves' disease: a feasibility study of the robotic transaxillary approach. ORL J Otorhinolaryngol Relat Spec (2014) 0.86
Detection and prevention of impending brachial plexus injury secondary to arm positioning using ulnar nerve somatosensory evoked potentials during transaxillary approach for thyroid lobectomy. Am J Electroneurodiagnostic Technol (2011) 0.84
Combined mycophenolate mofetil and prednisone therapy in tamoxifen- and prednisone-resistant Reidel's thyroiditis. Thyroid (2010) 0.84
The diagnostic value of parathyroid hormone washout after fine-needle aspiration of suspicious cervical lesions in patients with hyperparathyroidism. Laryngoscope (2013) 0.84
The nrf1 and nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells. Cancers (Basel) (2010) 0.83
Pancreatic regenerating protein I in chronic pancreatitis and aging: implications for new therapeutic approaches to diabetes. Pancreas (2008) 0.83
Robotic-assisted transaxillary parathyroidectomy of an atypical adenoma. Minim Invasive Ther Allied Technol (2011) 0.83
Can ultrasound be used as the primary screening modality for the localization of parathyroid disease prior to surgery for primary hyperparathyroidism? A review of 440 cases. ORL J Otorhinolaryngol Relat Spec (2011) 0.82
Ectopic secretion of parathyroid hormone in a neuroendocrine tumor: a case report and review of the literature. Int J Clin Exp Med (2011) 0.81
Reduced response of prostate cancer cells to TRAIL is modulated by NFkappaB-mediated inhibition of caspases and Bid activation. Int J Oncol (2002) 0.81
Pancreatic elastase is proven to be a mannose-binding protein--implications for the systemic response to pancreatitis. Surgery (2003) 0.81
Potential role for the nuclear transcription factor NF-kappa B in the pathogenesis of ureteropelvic junction obstruction. J Endourol (2002) 0.81
Imatinib mesylate (Gleevec) induces human corpus cavernosum relaxation by inhibiting receptor tyrosine kinases (RTKs): identification of new RTK targets. Urology (2013) 0.80
Functional androgen receptor confers sensitization of androgen-independent prostate cancer cells to anticancer therapy via caspase activation. Biochem Biophys Res Commun (2003) 0.80
Localization of peripheral dopamine D1 and D2 receptors in rat and human seminal vesicles. J Androl (2002) 0.79
Alternate incision-site thyroidectomy. Curr Opin Oncol (2014) 0.78
Is robotic hemithyroidectomy comparable to its conventional counterpart? Surgery (2013) 0.78
Factors associated with higher risk of complications after adrenal surgery. Ann Surg Oncol (2014) 0.78
In vivo proteomic analysis of cytokine expression in laser capture-microdissected urothelial cells of obstructed ureteropelvic junction procured by laparoscopic dismembered pyeloplasty. J Endourol (2003) 0.78
A postmenopausal woman with gross cystic disease fluid protein-15 and estrogen receptor-positive recurrence of papillary thyroid cancer. Thyroid (2010) 0.77
Robotic transaxillary thyroid lobectomy of a follicular neoplasm. Ann Surg Oncol (2012) 0.77
Early-onset breast cancer in a woman with Graves' disease. Int J Clin Exp Med (2012) 0.77
Expression of melanocortin receptors in human prostate cancer cell lines: MC2R activation by ACTH increases prostate cancer cell proliferation. Int J Oncol (2012) 0.76
Cholestatic hepatitis in a patient with Graves' disease resolved with total thyroidectomy. Trop Gastroenterol (2012) 0.76
The importance of surgical volume on outcomes in thyroid surgery revisited: old is in again : editorial response to "what's old is new again" by Julie Ann Sosa (doi: 10.1245/s10434-014-3850-z). Ann Surg Oncol (2014) 0.75
Brachial plexus compression: a rare sequelae of malignant papillary thyroid carcinoma. Int J Clin Exp Med (2013) 0.75
Management of erectile function by penile purinergic p2 receptors in the diabetic rat. J Urol (2009) 0.75
Early-onset breast disease: case of a Grave condition with a favorable prognosis. Int J Clin Exp Med (2012) 0.75
Recyclable single-stranded DNA template for synthesis of siRNAs. BMB Rep (2010) 0.75
Paraganglioma of the Organ of Zuckerkandl. J La State Med Soc (2012) 0.75
Retroperitoneal ganglioneuroma: an unusual cause for abdominal pain. Trop Gastroenterol (2012) 0.75
Image of the month--quiz case. Paraganglioma. Arch Surg (2011) 0.75
Thyroid hemiagenesis. J La State Med Soc (2012) 0.75
Lithium-Associated Hyperparathyroidism: A Pooled Analysis. ORL J Otorhinolaryngol Relat Spec (2015) 0.75
Kikuchi disease and thyroid follicular adenoma. Ear Nose Throat J (2010) 0.75
Robotic-assisted laparoscopic wedge resection of a gastric leiomyoma with intraoperative ultrasound localization. Minim Invasive Ther Allied Technol (2011) 0.75
Pathology quiz case 1. Kikuchi disease. Arch Otolaryngol Head Neck Surg (2011) 0.75
Thyroid cancer in black thyroid glands: the effect of age and race. ORL J Otorhinolaryngol Relat Spec (2015) 0.75
Are bilateral axillary incisions needed or is just a single unilateral incision sufficient for robotic-assisted total thyroidectomy? Arch Surg (2011) 0.75
Initial Experience With Biologic Polymer Scaffold (Poly-4-hydroxybuturate) in Complex Abdominal Wall Reconstruction. Ann Surg (2017) 0.75
Image of the month. Leakage of silicone gel implant. Arch Surg (2010) 0.75
Risk and Survival of Patients with Head and Neck Cutaneous Melanoma: National Perspective. Oncology (2017) 0.75
A case report of intraoperative endoscopic ultrasound during robotic assisted Heller myotomy for severe esophageal achalasia. J La State Med Soc (2011) 0.75
Thyroid hormone replacement therapy, surveillance ultrasonography, and fine-needle aspiration after hemithyroidectomy. Ann Otol Rhinol Laryngol (2013) 0.75
Retroauricular robotic thyroidectomy with concomitant neck-lift surgery. Ann Surg Oncol (2014) 0.75
Financial Implication of Radioactive Iodine Therapy for Early-Stage Papillary Thyroid Cancer. Oncology (2017) 0.75